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Abstract: The search for new antimicrobial compounds has gained added momentum in 
recent years, paralleled by the exponential rise in resistance to most known classes of current 
antibiotics. While modifications of existing drugs have brought some limited clinical success, 
there remains a critical need for new classes of antimicrobial compound to which key clinical 
pathogens will be naive. This has provided the context and impetus to marine biodiscovery 
programmes that seek to isolate and characterize new activities from the aquatic ecosystem. 
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One new antibiotic to emerge from these initiatives is the antibacterial compound tropodithietic 
acid (TDA). The aim of this study was to provide insight into the bioactivity of and the 
factors governing the production of TDA in marine Pseudovibrio isolates from a collection 
of marine sponges. The TDA produced by these Pseudovibrio isolates exhibited potent 
antimicrobial activity against a broad spectrum of clinical pathogens, while TDA tolerance was 
frequent in non-TDA producing marine isolates. Comparative genomics analysis suggested a 
high degree of conservation among the tda biosynthetic clusters while expression studies 
revealed coordinated regulation of TDA synthesis upon transition from log to stationary 
phase growth, which was not induced by TDA itself or by the presence of the C10-acyl 
homoserine lactone quorum sensing signal molecule. 
Keywords: TDA; Pseudovibrio; marine; antimicrobial; clinical 
 
1. Introduction 
Due to the misuse and overuse of antibiotics, the emergence of pathogens that are resistant to virtually 
all of the currently available antibiotics has reached a critical stage. For this reason, there has been an 
urgent drive towards the discovery of new antimicrobial compounds. The marine environment provides a 
relatively untapped source of these unique natural products. In particular, marine sponges are emerging 
as a goldmine of antimicrobial activity, with many potential bioactive compounds produced by symbiotic 
bacteria associated with marine sponges [1]. As sessile organisms, sponges rely on an arsenal of 
metabolites, generally produced by their associated microorganisms, to defend against disease and to 
gain a competitive advantage within the marine ecosystem [2]. This symbiotic relationship is essential for 
sponge efficiency and survival [3]. Consequently, more novel bioactive metabolites are retrieved from 
sponges each year than any other marine organism [2], with approximately 3500 novel marine compounds 
isolated from marine sponges since 1985 [4]. Recent evidence suggests that the majority of bioactive 
compounds isolated from sponges are likely to be produced by associated microbiota [5]. 
Pseudovibrio species are ubiquitous in the marine environment, and in particular within marine 
sponges. They were first isolated and described in 2004 from seawater in Taiwan [6] but have since been 
isolated from ascidians [7] tunicates [8], algae [9], coral [10], tube worms [11] and from a plethora  
of marine sponges [12–17]. Pseudovibrio is in fact believed to be one of the few confirmed vertically 
transmitted sponge symbionts, due to its association with sponge larvae [18]. Antimicrobial activity 
within Pseudovibrio sp. has been documented a number of times [12,15–17,19,20]. Moreover, 
Pseudovibrio species produce specific bioactive compounds, such as heptylprodigiosin [20] and 
biosurfactant compounds [11]. More recently, the antibacterial compound tropodithietic acid (TDA) 
was recovered from Pseudovibrio sp. D323, isolated from the red alga Delisea pulchra [9], which 
correlated with the previous prediction of TDA production by Pseudovibrio sp. strain JEO62 based on 
the presence of the tdaA-tdaF biosynthetic cluster in its genome [5,21]. TDA was initially isolated from 
several species within the Roseobacter clade including Phaeobacter inhibens and Ruegeria sp. [21–24]. 
TDA is a suphur containing compound with a unique structure consisting of a dithiet moiety fused to 
tropone-2-carboxylic acid, which is believed to co-exist with its tautomer, thiotorpocin [25], previously 
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identified in Pseudomonas sp. [26,27]. TDA has been shown to have a strong inhibitory activity against a 
range of marine bacteria, such as Proteobacteria, Actinobacteria, Firmicutes and Bacteroidetes, the fish 
pathogens Vibrio anguillarum and Vibrio splendidus [28] as well as marine algae [21] and a range of 
human pathogenic bacteria [24]. It has been proposed as a potential fish larval probiotic, as it has been 
shown not only to reduce mortality in the larvae of fish such as turbot and cod [29], but also that it has 
no toxic effects against the eukaryotic models C. elegans and Artemia sp. [30]. 
Here, we identify TDA production in Pseudovibrio species isolated from the marine sponges 
Axinella dissimilis, Polymastia boletiformis and Haliclona simulans and investigate phenotypic 
characteristics, bioactivity and molecular mechanisms of its production. 
2. Results and Discussion 
2.1. Culture Conditions Enhance the Production of Bioactive Compounds by Pseudovibrio Species 
A collection of 72 Pseudovibrio isolates from the marine sponges Axinella dissimilis,  
Polymastia boletiformis and Haliclona simulans, which were previously classified into 33 groups 
based on their RAPD profiles [31], was further investigated for antimicrobial activity. A representative 
strain from each RAPD group was tested for bioactivity via a spot-plate overlay assay on both SYP-SW 
and marine (MA) agar, against the indicator strain S. aureus NCDO 949. Zones of inhibition were 
produced by 26 of the 33 representatives of the RAPD groups on SYP-SW. Interestingly, all these strains 
displayed higher levels of inhibition when grown on MA than on SYP-SW (Figure 1), while 5 strains 
displayed antimicrobial bioactivity only when grown on MA. Two strains displayed no bioactivity 
against S. aureus NCDO 949 on either media (Supplementary Table S1). 
Figure 1. Overlay assay with tropodithietic acid (TDA) producing Pseudovibrio isolate 
WC22—representative of most Pseudovibrio isolates. S. aureus NCDO949 was used as an 
indicator strain and was strongly inhibited when the Pseudovibrio colony had turned brown. 
(a) Marine agar; and (b) starch-yeast extract-peptone–sea water (SYP-SW)_agar.  
 
In order to establish the spectrum of bioactivity produced by the marine isolates, each individual 
isolate was tested against a range of clinical and fish pathogens, as well as a number of laboratory strains 
(Supplementary Table S2). High levels of inhibition were seen in 31 of the 33 strains against both 
clinical and fish pathogens (Table 1). The vast majority of the isolates displayed antibacterial activity 
against V. anguillarum (88%), E. tarda (88%), Y. ruckerri (94%), E. coli MUH (82%), E. coli NCIMB 
(85%), M. morganii (88%), S. Typhimurium LT2 (52%), S. Typhimurium C5369 (76%), P. sputonum 
(64%), S. arizonae (67%) and S. aureus NCDO 949 (94%). Interestingly, each of the 31 isolates showing 
antimicrobial bioactivity produced a characteristic brown pigment when grown on MA. This brown 
pigment was not produced by the two strains which showed no inhibitory activity. This strongly suggested 
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a direct association between pigment production and the antimicrobial bioactivity. Four  
Pseudovibrio isolates which produced the brown pigment and displayed particularly potent levels of 
bioactivity—namely W64, W69, W74 and W89—were selected for further analysis. 
Table 1. Antimicrobial activity of the 33 RAPD group representatives against a range of 
human and fish pathogens. 
Strain 
Antagonistic Activity against Pathogen 
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JIC5 +++ +++ +++ ++ + +++ - ++ * + * + * ++ 
JIC6 + ++ + - + * + * - - + * - ++ 
JIC17 +++ ++ + - + * ++ + * - + * + * + 
W10 +++ ++ - + - + * - +* + * - + 
W19 - - - - - - - - - - - 
W62 +++ ++ ++ + + * +++ - + * ++ * - ++ 
W63 +++ +++ - - - - - ++ * +++ * + * ++ 
W64 +++ +++ +++ + + +++ ++ * ++ * ++ ++ ++ 
W65 +++ ++ +++ ++ + +++ + * ++ * + * + ++ 
W69 +++ +++ ++ + + ++ ++ * ++ * ++ * ++ * ++ 
W71 +++ ++ ++ + + +++ + * ++ * + * + + 
W89 +++ +++ +++ + ++ ++ ++* ++ * ++ * + ++ 
W99 +++ +++ +++ ++ + +++ + * ++ * + * + ++ 
WC43 ++ - ++ + * + + * + * + * + * + ++ 
W74 +++ ++ + + ++ +++ + * ++ * + * ++ * + 
W85 +++ ++ +++ ++ + * + + * + * + * - ++ 
W78 ++ + ++ + * + * +++ +* + * + * - + 
W94 ++ + ++ + * + * ++ + * + * + * + * ++ 
W96 +++ ++ ++ + * + * ++ + * ++ * - ++ * + 
WM31 +++ ++ +++ + * + * + + * + * - - ++ 
WM33 ++ + + + * + * - + - - - + 
WM34 +++ ++ +++ + * + * +++ + * + * + * + * ++ 
WM40 +++ ++ ++ + + ++ - ++ ++ * ++ * ++ 
WM50 - - - - - - - - - - - 
WC13 +++ ++ ++ + + * ++ - + * - + * ++ 
WC15 + - + * - - + * - - - - + 
WC21 ++ + * ++ + + * ++ - + * - + * ++ 
WC22 +++ + + + + * + - - - + * ++ 
WC30 +++ + ++ + + * + - + * - + * + 
WC32 +++ ++ ++ ++ + * ++ - ++ * + * + * ++ 
WC41 +++ ++ ++ + + * ++ - ++ * - ++ * ++ 
HC6 +++ ++ +++ ++ * + +++ + * ++ * + * + * ++ 
HMMA3 ++ + ++ + * + * + * + * - - - + 
Diameter of growth inhibition (mm): + ≥1 mm; ++ ≥2 mm; +++ ≥4 mm. * partial inhibition. Blue: fish 
pathogen, yellow: laboratory strain, red: human pathogen. 
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2.2. Pseudovibrio Species Derived from Marine Sponge Produce Tropodithietic Acid (TDA) 
Previously the production of a brown pigment associated with antimicrobial activity by 
Tropodithietic Acid (TDA) producing marine isolates on MA has been reported [28,32], and high levels 
of activity of TDA against fish pathogens has been documented a number of times [23,30,33] as has 
activity against human pathogens [24]. While chemical analysis of the pigment has yet to be reported, 
it has been shown to rely on the same biosynthetic genes as TDA itself, suggesting a direct link to the 
antimicrobial compound [34]. Thus, the pigmented antimicrobial activity of the Pseudovibrio isolates may 
be due at least in part to TDA. To establish that the Pseudovibrio isolates were indeed producing TDA,  
a method adapted from Porsby et al. [24] for the isolation of TDA was employed to extract compounds 
from the four Pseudovibrio isolates with high levels of antimicrobial activity. TLC was performed on the 
Pseudovibrio extracts and plates were overlaid with S. aureus NCDO 949 and tetrazolium salt. A large 
zone of inhibition was observed at the position correlating to an Rf value of 0.71, the same as the TDA 
control, suggesting that the compound produced by the Pseudovibrio isolates W64, W69, W74 and W89 
was the secondary metabolite TDA (Figure 2a). 
To further confirm the production of TDA by these isolates, the bioactive compounds extracted from 
the Pseudovibrio isolates were analysed via UHPLC-DAD-qTOFMS. This analysis confirmed the 
presence of TDA in the extract based on an identical retention time as an authentic reference standard, 
and the unique accurate mass of the [M + H]+ ion (212.9674 ± 0.005) as well as correct isotopic pattern 
of C8H4O3S2 (Figure 2b), unambiguously identifying TDA. 
Figure 2. (a) TLC-overlay assay of extracts from Pseudovibrio isolates. S. aureus NCD0 949 
was used as an indicator strain. The concentration of the TDA control was 0.01 mg/mL;  
(b) UHPLC-DAD-qTOFMS data, showing the extracted ion chromatograms (212.9674 ± 
0.005) of the [M + H]+ ion of TDA. Analysis demonstrated that the bioactive compound 
produced by 4 Pseudovibrio isolates was tropodithietic acid.  
 
2.3. TDA-Producing Isolate W74 has Limited Activity against Marine Isolates 
Having established that the TDA-producing isolates were active against a range of clinical and fish 
pathogens, we sought to investigate if TDA had an inhibitory effect against bacteria isolated from a 
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similar environment or whether these bacteria would have some level of resistance against TDA, due 
to their close association. Therefore, the antimicrobial activity of W74 was tested against a range of 
marine bacteria isolated from 2 deep sea sponges, namely Hexactinellida and Poecillastra species. W74 
was spot-plated and overlaid with 136 different marine isolates to screen for tolerance against TDA.  
Of the 136 isolates, 126 (93%) displayed tolerance to TDA. Tolerant species included Psychrobacter, 
Alteromonas, Salinibacter, Alcanivorax, Flavobacterium and Micrococcus species. Strains displaying 
sensitivity towards TDA included Staphlococcus species, as well as species of the genera Idiomarina 
and Rhodococcus. 
The tolerant strains were subsequently tested for TDA production. No brown pigment production was 
observed in the TDA resistant marine isolates grown for 72 h from a starting OD600 of 0.01, suggesting 
that the isolates tested were not TDA producers. For confirmation of this, 12 resistant isolates were 
selected for compound extraction and tested for the presence of TDA using TLC spot-plate assays 
(Supplementary Table S3). All isolates tested negative for TDA production. These findings were 
interesting, as resistance to TDA has previously only been observed in TDA-producers alone [9,22,35]. 
A selection of 4 TDA sensitive isolates was also compound extracted and tested for TDA production,  
3 of the 4 isolates tested negative for TDA production (Supplementary Table S3). 
Interestingly, the Pseudovibrio strain W19, isolated from Axinella dissimilis and previously shown to 
have limited antimicrobial activity was found not to produce TDA using TLC analysis and was resistant 
to TDA extracted from W74. The resistance of non-producing W19 to TDA further suggests that the 
prevalence of TDA resistance mechanisms may be more widespread within marine communities than 
previously thought. 
2.4. TDA Extracted from Pseudovibrio Displays Bioactivity against Cystic Fibrosis (CF)  
Clinical Isolates 
Following the observed high levels of antimicrobial activity Pseudovibrio isolates displayed against 
a range of human pathogens, both previously [24] and this study, as well as the inhibitory effect displayed 
against the CF isolate P. sputorum, the effect of TDA extracted from the Pseudovibrio strain W74  
was tested against a range of clinical isolates collected from the sputum of paediatric patients with CF 
from Cork University Hospital. TDA displayed antimicrobial activity against a number of CF isolates, 
namely Bacillus cereus, Staphylococcus aureus, Staphylococcus epidermidis, Micrococcus luteus and 
Streptococcus haemolyticus. Preventing chronic infection is essential in the maintenance of health in 
CF patients; hence it is of the outmost importance that suitable antibiotics are used to treat infection 
successfully. S. aureus has been shown to be the most common Gram positive organism found in  
the lungs of patients with cystic fibrosis, as well as being the second most persistent pathogen after  
P. aeruginosa [36]. Its sensitivity to TDA is all the more significant due to the fact that the above study 
revealed that S. aureus was not eliminated completely by oral antibiotics. The sensitivity of CF isolates 
to TDA was particularly interesting, as very little is known about the effect of TDA against clinical 
isolates. However, while a recent study by Neu et al. revealed that TDA has no toxicity when tested on 
the eukaryotic models Artemia sp. and Caenorhabditis elegans [30], further tests on animal models 
would be required before TDA could be considered as a suitable antibiotic for clinical use. 
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2.5. Genomic Pathway 
The TDA biosynthetic cluster was found in the draft genome sequences from the three marine isolates 
W64, W74 and WM33 after a NCBI BLAST+ 2.2.29 homology search using the TDA genes from 
Ruegeria sp. TM1040 [37] as query. The gene sequence identifier for each tdaA-F homolog found in the 
draft genome sequences is reported in Table 2. All-vs-all homology comparison of the 6 genes involved 
in the TDA pathway for the different species [18,33,38,39] (Table 2) and the graphical representation 
was conducted by Circoletto [40] (Figure 3). The results from the all-vs-all comparative analysis indicate 
that the tda genes show a high degree of homology in all five marine Pseudovibrio isolates (>94%  
of similarity). Interestingly, of the 3 isolates tested in this study, we observed that W74 consistently 
produced higher levels of TDA when compared with other isolates under the same extraction conditions 
that cannot be fully explained by the sequence similarity. This higher level of TDA production was 
independent of any growth effects and may be due to differences in the regulation or production of 
TDA among marine isolates. 
Figure 3. Comparative analysis of the TDA genes from Pseudovibrio compared to 
Ruegeria sp. TM1040. As expected, Pseudovibrio isolates exhibited the highest degree of 
sequence similarity to each other. Ribons represent the degree of sequence similarity with 
red being most similar and green signifying least similarity. Outer rings represent the coverage 
of sequence similarity in each gene as indicated by each coloured connecting line. See 
Supplementary Tables S4–S9 for the detailed similarity values between each pair of genes. 
 
As the synthesis of TDA in Pseudovibrio isolates has not been characterised, we undertook to 
investigate the factors governing production of this important antimicrobial compound. Given that 
W74 produced the highest amounts of TDA under culture conditions, this isolate was selected for 
further analysis. 
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Table 2. Accession number for the six genes involved in the TDA pathway from the different 
species used in the comparative genomic analyses. 
Strain Accession Numbers of tda Genes 
 tdaA tdaB tdaC tdaD tdaE tdaF 
W64 W64_g2177 W64_g2176 W64_g2175 W64_g2174 W64_g2173 W64_g2160 
W74 W74_g3196 W74_g3195 W74_g3194 W74_g3193 W74_g3192 W74_g3180 
WM33 WM33_g4179 WM33_g4178 WM33_g4176 WM33_g4175 WM33_g4174 WM33_g4161 
FO-BEG1 [38] PSE_2264 PSE_2263 PSE_2261 PSE_2260 PSE_2259 PSE_2247 
JE062 [18] JE062_g1641 JE062_g1639 JE062_g1638 JE062_g1637 JE062_g1636 JE062_g1624 
TM1040 [37] EF139200 EF139201 EF139202 EF139203 EF139204 EF139205 
Phaeobacter 
gallaeciensis DSM 
17395 [33] 
PGA1_262p00980 PGA1_262p00970 PGA1_262p00960 PGA1_262p00950 PGA1_262p00940 PGA1_262p00810 
Phaeobacter 
gallaeciensis 2.10 [33] 
PGA2_239p0970 PGA2_239p0960 PGA2_239p0950 PGA2_239p0940 PGA2_239p0930 PGA2_239p0800 
Phaeobacter 
gallaeciensis 2.10 [39] 
Pden_1600 Pden_1599 Pden_1615 Pden_1614 Pden_1613 Pden_1605 
2.6. TDA Expression Occurs during Logarithmic Growth 
In order to determine at what point in the life cycle of Pseudovibrio TDA production occurs, W74 
was grown under shaking conditions over a period of 48h. The growth was measured and production 
of the brown pigment was noted at 0, 6, 12, 24, 30, 36, and 48 h (Figure 4A,B). An aliquot of culture 
was collected for compound extraction at each time point, and bioactivity was tested by spotting 
extracted TDA on a TLC plate overlaid with the indicator strain S. aureus NCDO 949. 
The colour change of W74 from opaque to brown occurred between 12 and 24 h, during the logarithmic 
stage of growth. From this point until the assay was completed at 48 h—i.e., from logarithmic stage until 
late stationary phase—strong bioactivity was seen in the extract. Clear zones of inhibition of S. aureus 
NCDO 949 occurred where extracts were spotted (Figure 4C). This demonstrates that TDA production 
is initiated during the logarithmic growth phase. Microscopy of samples demonstrated that after 6 h 
(before colour change) cells were rod-shaped and existed in a planktonic form. However, subsequent  
to colour change (after 24 h), cells aggregated together in a rosette formation. This cell aggregation has 
previously been shown to be associated with the production of TDA in the Silicibacter strain TM1040 [37] 
and strains of Ruegeria and Phaeobacter [22,23,28] (Supplementary Figure S1). It is interesting to note 
that, although production of TDA occurred in both shaking and static cultures of W64 and W74, the 
amount of pigment production was much larger in the shaking cultures compared to those grown under 
static conditions. Furthermore, bacterial density was over 2-fold higher for isolates grown in shaking 
rather than static conditions. This is inconsistent with the findings of Bruhn and co-workers [35], who 
found that while cell density was up to 10-fold higher in shaking cultures, pigment production was only 
present in static cultures. It also contrasts markedly with the observations of Belas and colleagues [21,41] 
who demonstrated than TDA production was minimal in shaking cultures, and that of D’Alvise et al. [29] 
who showed that TDA expression in the Roseobacter clade species Ruegeria mobilis was only associated 
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with attached or biofilm associated cells. This provides further evidence suggesting that differences 
exist in the regulation of TDA production in marine isolates. 
Figure 4. Timecourse experiment (0–48 h) for the production of TDA by Pseudovibrio 
strain W74. (A) Growth curve assay; (B) Pigment production; and (C) TLC-overlay assay 
of ethyl-acetate extracts obtained from W74 at the respective timepoints. TDA is included 
at a concentration of 0.02 μg/mL. 
 
2.7. Induction of TDA Genes in Pseudovibrio is Linked to Bioactivity 
Gene expression profiles were generated by Real Time RT-PCR on samples of Pseudovibrio isolate 
W74 at 0, 6, 12, 24, 30, 36, and 48 h time points in order to examine the kinetics of expression governing 
TDA production. The expression of 6 genes involved in the TDA pathway—namely tdaA, -B, -C, -D, -E 
and -F, normalized to gyrB, was investigated. All genes were expressed by 24 h, with induction occurring 
almost simultaneously, demonstrating that the expression levels of genes involved in the TDA pathway 
was directly correlated to brown pigment formation and bioactivity. In all cases, expression levels dropped 
by 48 h—i.e., late stationary phase (Figure 5). Induction and subsequent decline in expression of the genes 
encoding TDA strongly suggests that production of TDA is tightly controlled in Pseudovibrio isolates,  
as would be expected for an energy expensive process. A previous study has shown TDA production in 
Phaeobacter gallaeciensis (inhibens) to be under the control of quorum sensing 3OHC(10)-HSL (QS) [34], 
thus, the induction of TDA production in logarithmic growth, coupled with the reduction in gene 
expression in late stationary phase, suggested that quorum sensing may be involved in controlling TDA 
production in Pseudovibrio and warranted further investigation. Furthermore, studies have shown TDA 
to be auto induced, whereby TDA induced its own synthesis, in Silicibacter (Ruegeria) sp. and has been 
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suggested to act as a QS signal [21]. Therefore, both auto-induction and QS-regulation of TDA were 
investigated in Pseudovibrio W74. 
Figure 5. RT-PCR Data. TdaA and tdaB genes involved in the production of TDA were 
expressed at 24 h—directly correlating to both bioactivity and brown pigment production 
in cultures. 
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2.8. TDA is Not Autoinduced, or Induced by C10-AHL 
In order to determine if TDA is auto-induced or induced by the QS molecule 3-OH-C10-HSL, W74 was 
grown in the presence or absence of TDA (1 μM), or 3-OH-C10-HSL (100 nM) respectively. Growth 
dynamics were identical in control and test cultures over 36 h (Figure 6A). In all cases brown pigment 
was produced at the same time interval (between 24 and 36 h) (Figure 6B). Previously, we had shown 
induction at 24 h, and the delay observed here is likely due to the presence of MeOH and DMSO in the 
media, resulting in delayed entry into logarithmic stage of growth. Cultures were compound extracted 
at each time point. All extracts—including a control of W74 grown in MB—showed TDA production 
at 36 h, suggesting that TDA production is not autoinduced or induced by 3-OH-C10-HSL. 
Research by Geng and co-workers [37] revealed that TDA produced by Silicibacter (Rugeria) and 
Pseudovibrio species induced the transcription of tdaC in a TDA-producing Ruegeria sp. Autoinduction 
was not observed in our marine isolates, further evidence that production of this secondary metabolite 
is not uniform among marine isolates. However, further analysis and functional genomics studies will 
be required to determine the factors underlying this divergence. 
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Figure 6. No evidence for autoinduction by TDA or early induction by QS compounds.  
(a) Growth curve of Pseudovibrio strain W74 grown in the presence of C10-HSL and TDA, 
along with the relative controls DMSO and MeOH; (b) Brown pigment production between 
24 and 36 h. Up to 24 h, cultures remained a light beige colour. No difference is seen in  
the growth or colour of W74, indicating that TDA is not auto-induced, nor is it induced  
by C10-HSL. 
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3. Materials and Methods  
3.1. Growth Conditions 
All Pseudovibrio strains were isolated from the sponges Axinella dissimilis Polymastia boletiformis and 
Haliclona simulans as previously described [16]. A selection of marine isolates from the UCC marine 
culture collection, previously isolated from the deep sea sponges of Hexactinellida and Poecillastra 
species, were used as indicator strains for TDA sensitivity assays. All marine sponge isolates were grown 
in the dark at 23 °C shaking at 200 rpm. Strains were grown on marine agar (MA) (Difco, Difco 
laboratories, Surray, KT8 2SE, UK), or SYP-SW agar (1% starch, 0.4% yeast extract, 0.2% peptone, 
3.3% sea salt, 1.5% agar). Other bacterial isolates (indicator strains) were grown shaking at 200 rpm at 
37 °C in LB (1% tryptone, 0.5% yeast extract, 0.5% salt). 
3.2. Antimicrobial Spot-Plate Overlay Assay 
Fifty microliters of Pseudovibrio strains grown overnight on Difco marine broth (MB, Difco 
laboratories, Surray, KT8 2SE, UK) were spotted at an OD600 of 0.2 onto MA or SYP-SW agar and 
incubated at 23 °C for 72 h. Bacterial indicator strains were grown overnight in LB and overlaid in 
0.5% LB agar at an OD600 of 0.1. Zones of inhibition were measured after 24 h of incubation at 37 °C. 
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3.3. Compound Extraction 
Compounds were extracted following a protocol adapted from Porsby et al., [24]. Briefly, Pseudovibrio 
strains were inoculated from an overnight culture into 10ml MB at an OD600 of 0.01 and incubated shaking 
at 150 rpm at 23 °C for >72 h (or until brown colour change occurred). The culture was then centrifuged 
(4472× g @ RT) and filtered through a 0.2 micron filter (514-0061 VWR, VWR International Ltd., 
Dublin, Ireland). Equal volume ethyl acetate (10 mL) plus 100 μL formic acid were added to the  
cell-free supernatant and incubated shaking at 23 °C at 200 rpm for 10 min. Samples were centrifuged 
at 4472× g for 10 min. Subsequently, the upper layer was removed and vacuum concentrated at 50 °C 
until dry. The dried compound was then resuspended in relevant mobile phase, i.e., 100 μL of MeOH for 
TLC and 200 μL of 85% acetonitrile/15% MilliQ water for UHPLC analysis.  
3.4. Thin Layer Chromotography (TLC) 
Two microliters of extracts were spotted on a Silica gel TLC plate (60 F254, MERCK Millipore, 
Cork, Ireland). 2 μL of 10 μg/mL TDA (BVT-0152, BioViotica, Dransfeld, Germany), redissolved in 
MeOH was used as a control. The solvents used were dichloromethane and methanol at a ratio of 
92.5:7.5, plus 0.15% acetic acid. When the front approached the top of the TLC plate, the plate was 
removed, dried and overlaid with 25 mL 0.5% LB agar containing bacterial indicator strains at an 
OD600 of 0.1, plus 5 mM 2,3,5-Triphenyltetrazolium Chloride (T8877, Sigma, St Louis, MO, USA) as 
a redox indicator of bacterial metabolism [42]. Plates were incubated for 24 h at 37 °C for pathogenic 
and laboratory indicator strains, and at 23 °C for marine isolates. 
3.5. TDA Identification 
Pseudovibrio extracts were redissolved in 200 μL 85% acetonitrile/15% MilliQ water. TDA standard 
solutions were diluted in 85% acetonitrile/15% MilliQ from a 1 mM TDA (BioViotica, Dransfeld, 
Germany) solution in dimethyl sulfoxide. UHPLC-DAD-qTOFMS analysis was conducted on an Agilent 
1290 UHPLC coupled to an Agilent 6550 qTOF (Santa Clara, CA, USA) equipped with a dual electrospray 
source [43]. 
Separation was performed at 40 °C on a 2.1 mm ID, 50 mm, 1.8 μm Agilent Eclipse Plus C18 
column [44] using a water-acetonitrile gradient solvent system, with both water and acetonitrile 
containing 20 mM formic acid. Using a flow of 0.8 mL/min, the gradient was started at 15% acetonitrile 
and increased to 60% acetonitrile within 1.8 min, then to 100% in 0.2 min, keeping this for 0.8 min, 
returning to 15% acetonitrile in 0.2 min, and equilibrating for the next sample in 1.5 min (total runtime 
4.5 min). TDA was determined in ESI+ mode and quantified from its [M + H]+ ion 212.9674 ± 0.005 
with the same retention time as the authentic standard (1.05 min). The TDA standard had a concentration 
of 0.01 mg/mL. Quantification was done using regression based on the peaks area in the Agilent 
MassHunter Quant 6.0 software (Agilent Technologies, Santa Clare, CA, USA). 
3.6. Antimicrobial Spot-Plate Overlay Assay for Marine Sponge Isolates 
The Pseudovibrio isolate W74 was spot-plated (5 μL) on MA at a starting OD600 of 0.2, and incubated 
at 23 °C for 72 h. Deep sea marine sponge isolates were grown overnight and inoculated into soft 0.5% 
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marine agar at an OD600 nm of 0.1. This was overlaid onto W74 spot-plates and incubated at 23 °C. 
Zones of inhibition were measured after 24 h. 
3.7. Pseudovibrio Induction Assay 
Pseudovibrio strain W74 was inoculated from an overnight culture into 3 × 200 mL MB in 1 L flasks, 
at OD600 nm of 0.01 in the presence of 100 nM 3-OH-C10-HSL (University of Nottingham, 
Nottingham, UK), or 1 μM TDA, to test for the induction and autoinduction of TDA, respectively. 
W74 was also grown in the presence of 100 μL of both DMSO and MeOH, as C10-HSL and TDA 
were suspended in these respectively. W74 was also grown in marine broth as a control. Cultures were 
incubated at 200 rpm at 23 °C, and the OD600 of the cultures was measured at 12 h, 18 h, 24 h and  
36 h. The colour of the cultures was also observed and noted at the above time points, at which times 
TDA was also extracted from the samples and analysed via TLC overlayed with S. aureus NCD0 949 
as indicator strain. 
3.8. RNA Isolation and cDNA Synthesis 
Pseudovibrio strain W74 was grown shaking in 20 mL MB in a 100 mL flask at 23 °C for 48 h. 
Growth was measured at 6, 12, 24, 30, 36 and 48 h and a growth curve was plotted. At the above time 
points, 500 μL culture was collected and stored in 1 mL RNA protect. RNA was isolated as per the 
RNeasy RNA Extraction Kit protocol (Qiagen GmbH, Hilden, Germany). Isolated RNA was 
subsequently treated with DNase (0.1 volume 10× Turbo DNase) and incubated at 37 °C for 30 min to 
remove any potentially contaminating DNA. DNase was then inactivated using 0.1 volume DNase 
inactivation reagent. A 16S targeted PCR using 63F and 1387R primers was performed on the isolated 
RNA to test whether the DNase treatment had been successful [45]. RNA was converted to cDNA 
using AMV Reverse Transcriptase (Promega, Madison, WI, USA), RNasin (100 U/μL) (Promega, 
Madison, WI, USA), random primers (0.5 μg/μL) (Promega, Madison, WI, USA) and 10 mM dNTPs 
(Promega, Madison, WI, USA). A 16S targeted PCR was also performed using 63F and 1387R 
primers to ensure cDNA integrity. 
3.9. RT-PCR 
Quantitative RT-PCR analysis of six genes (tdaA-F) involved in TDA production was performed on 
W74 cDNA using primers outlined in Supplementary Table S9. Specific RT-PCR primers and probes 
were designed using the Universal ProbeLibrary assay center [46] for each gene based on the W74 
genome sequence. Ten serial dilutions of the gDNA standards from 108 to 104 copies were prepared and  
2 blanks were used as a control. Quantitative real-time PCR analysis of expression was carried out using 
the FastStart TaqMAN probe master kit (12747422, Roche, Basel, Switzerland). cDNA samples were 
diluted 1/10, and 5 μL was added to the following mixture: 12.5 μL Probemaster, 0.2 μL probe, 0.5μL 
forward primer, 0.5 μL reverse primer (Supplementary Table S9), 6.3 μL H2O. The mixture was 
incubated at 95 °C for 5 min, followed by 50 cycles at 95 °C for 40 s, 55 °C for 2 min, and 72 °C for  
1 min. Quantitative real time-PCR signals were normalized to the constitutively expressed housekeeping 
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gene gyrB. This gene was chosen on the basis that it is universally used for normalization of gene 
expression data in a broad spectrum of microbial species [47,48]. 
3.10. Genetic Analysis of Pseudovibrio TDA Genes 
The 6 genes involved in the TDA pathway in Ruegeria sp. TM1040 [37] (Table 2) were used as a 
query to identify their homologs in the draft genomes of the three Pseudovibrio sp marine isolates W64, 
W74 and WM33 using NCBI BLAST+ 2.2.29 [49]. All-vs-all homology comparison of the 6 genes 
involved in the TDA pathway for the different species (Table 2) and the graphical representation was 
conducted by Circoletto [40]. 
4. Conclusions 
In this study, we have characterised the production and spectrum of activity of TDA from marine 
sponge bacterial isolates, while also revealing an apparent lack of auto-induction or of QS induced 
early induction of TDA production in Pseudovibrio. In contrast to previous studies, tolerance to TDA, 
which was prevalent among marine sponge isolates, was not associated with native TDA production in 
these strains. TDA was shown to be active against a broad spectrum of human and fish pathogens, 
including M. morganii and Pandoraeae sputonum, both multidrug resistant opportunistic pathogens 
commonly associated with nosocomial infections [10,50–53]. TDA-producing Pseudovibrio isolates 
also displayed antimicrobial activity against Salmonella enterica ssp. arizonae, a serious albeit 
uncommon multidrug-resistant human pathogen which can cause life-threatening infections, usually  
in immunocompromised hosts [54–56]. S. aureus, one of the top three pathogens of blood stream 
infections [53], also displayed sensitivity to TDA produced by Pseudovibrio isolates. As the search for 
new antibiotics continues, TDA produced by marine sponge isolates has potential as a platform molecule 
for clinical development. Indeed, synthetic modification of the TDA framework resulting in analogues with 
enhanced antimicrobial activity has recently been reported [57], evidence that chemical modification of 
the compound can be achieved. Furthermore, initial toxicity studies have revealed that TDA is  
non-toxic in two eukaryotic models [30]. However, more detailed understanding of the molecular 
mechanisms governing TDA production is needed to underpin the necessary development process. 
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